Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure
Author(s) -
Jeanne E. Poole,
George Johnson,
Anne S. Hellkamp,
Jill Anderson,
David J. Callans,
Merritt H. Raitt,
Ramakota Reddy,
Francis E. Marchlinski,
Raymond Yee,
Thomas Guarnieri,
Mario Talajic,
David J. Wilber,
Daniel P. Fishbein,
Douglas L. Packer,
Daniel B. Mark,
Kerry L. Lee,
Gust H. Bardy
Publication year - 2008
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa071098
Subject(s) - medicine , hazard ratio , shock (circulatory) , cardiology , ventricular fibrillation , implantable cardioverter defibrillator , heart failure , proportional hazards model , ventricular tachycardia , confidence interval , tachycardia
Patients with heart failure who receive an implantable cardioverter-defibrillator (ICD) for primary prevention (i.e., prevention of a first life-threatening arrhythmic event) may later receive therapeutic shocks from the ICD. Information about long-term prognosis after ICD therapy in such patients is limited.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom